5.5
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reducti…
Reductive reactions introduce electrons to drug molecules, affecting polar functional groups like hydroxy and amino, allowing subsequent biotransformation or conjugation.
Carbonyl group reductions transform aliphatic carbonyl compounds and aromatic and alicyclic ketones to alcohols. For example, naltrexone transforms into its isomorphine derivative.
C=C reductions, as seen in steroids like norethindrone, convert double bonds into single bonds. Alcohols undergo dehydration to alkenes before reduction, as exemplified by the metabolites of the antispasmodic drug bencyclane.
N-compound reductions transform nitro, azo, and N-oxide groups to their reduced forms. For instance, nitro reduction in nitrazepam proceeds via nitroso and hydroxylamine intermediates to yield an amine.
Prontosil, an azo drug, undergoes reduction to active sulfanilamide, while imipramine N-oxide is converted to imipramine.
Miscellaneous reductive reactions encompass various reduction processes in drug metabolism.
The anesthetic halothane undergoes reductive dehalogenation, and is converted to trifluoroacetic acid or its derivatives.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main purpose of reductive reactions in drug metabolism?
Reductive reactions introduce electrons to drug molecules, modifying lipophilic drugs by introducing or revealing polar functional groups. Enzymes called reductases catalyze these reactions, transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. This process is essential for drug detoxification and elimination from the body.
Q2: How do carbonyl group reductions work in drug metabolism?
Carbonyl group reduction is an essential reductive reaction where aldehydes and ketones are reduced to alcohols. For example, naltrexone transforms into its isomorphine derivative through this process. Enzymes like aldehyde dehydrogenase catalyze the conversion of acetaldehyde to ethanol, demonstrating how carbonyl compounds are enzymatically reduced to their alcohol forms.
Q3: What happens to carbon-carbon double bonds during reductive drug metabolism?
Carbon-carbon double bonds are reduced to single bonds through enzymatic processes. Steroids like norethindrone undergo C=C reductions, converting their double bonds into single bonds. Enzymes like cytochrome P450 reductase catalyze these transformations, making drugs more water-soluble for subsequent biotransformation or conjugation.
Q4: How are nitro and azo compounds reduced during phase I metabolism?
Nitro groups are reduced to amino groups through nitroreductase enzymes, proceeding via nitroso and hydroxylamine intermediates. For instance, nitrazepam undergoes nitro reduction to yield an amine. Azo compounds like prontosil are reduced by azoreductases to active metabolites such as sulfanilamide, demonstrating how N-compounds transform during drug metabolism.
Q5: What role do N-oxide reductions play in drug biotransformation?
N-oxide reductions convert N-oxide groups to their reduced forms, representing an important class of reductive reactions. Imipramine N-oxide is converted to imipramine through this process. These reductions help modify drug structure and enhance water solubility, facilitating subsequent phase II conjugation reactions for drug elimination.
Q6: What are examples of miscellaneous reductive reactions in drug metabolism?
Miscellaneous reductive reactions encompass various reduction processes beyond carbonyl and double bond modifications. The anesthetic halothane undergoes reductive dehalogenation, converting to trifluoroacetic acid or its derivatives. These diverse reductive pathways demonstrate how different functional groups can be modified through enzymatic reduction to facilitate drug detoxification.
Q7: How do reductive reactions prepare drugs for subsequent biotransformation steps?
Reductive reactions introduce or reveal polar functional groups on drug molecules, creating reactive sites for subsequent biotransformation or conjugation. By converting lipophilic drugs into more polar, water-soluble metabolites, these reactions facilitate the action of phase II enzymes. This sequential modification process is critical for complete drug metabolism and efficient elimination from the body.